Walnut Creek, CA, United States of America

Eileen Beall


Average Co-Inventor Count = 5.0

ph-index = 4

Forward Citations = 112(Granted Patents)


Company Filing History:


Years Active: 2000-2001

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Celebrating the Contributions of Inventor Eileen Beall

Introduction: Eileen Beall, a distinguished inventor based in Walnut Creek, California, has made significant strides in the field of biotechnology, particularly in the area of hepatitis C virus research. With a total of four patents to her name, her work has the potential to impact diagnostic and therapeutic methods greatly.

Latest Patents: Among her latest inventions, Eileen has developed patents related to HCV genomic sequences for diagnostics and therapeutics. These patents feature nucleic acid, peptide, and antibody compositions that are crucial for identifying various genotypes of the hepatitis C virus. The methods she has devised for using these compositions are set to enhance both diagnostics and therapeutic approaches, positioning her as a key figure in the fight against this global health issue.

Career Highlights: Eileen Beall's innovative spirit and dedication to research have propelled her career within the Chiron Corporation, a company renowned for its contributions to the biotechnology sector. Her commitment to advancing medical science is evident through her prolific patenting activity and her relentless pursuit of solutions for complex health challenges.

Collaborations: Throughout her career, Eileen has worked alongside talented professionals like Tai-An Cha and Bruce D. Irvine. These collaborations have fostered an environment of shared knowledge and creativity, leading to impactful innovations in their field.

Conclusion: Eileen Beall's contributions to oncology and diagnostics are remarkable, reflecting her expertise and innovative mindset. Her work exemplifies the crucial role that inventors play in transforming scientific research into practical applications that can improve health outcomes worldwide. Her ongoing efforts in partnership with notable colleagues ensure that the future of hepatitis C diagnostics and therapeutics remains bright.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…